mRNA Technology Market: Worldwide Study on Top Players | Moderna Therapeutics, BioNTech, Ethris, CureVac, Argos Therapeutics, Sangamo Therapeutics Inc., Pfizer Inc

Global mRNA Technology Market Analysis and Forecast 2020-2030
Market Introduction:

The global mRNA technology market is expected to exhibit a marginal growth rate of 1.8% during the forecast period of 2022-2030. One of the major factors driving the market growth is the increased prevalence of medical disorders such as diabetes, tuberculosis (TB), cancer, and cardiovascular diseases (CVDs). The industry is also benefiting from the rising demand for therapeutic drugs and vaccines for COVID-19, Ebola, influenza, infectious and chronic diseases such as HIV, and other viral illnesses.

Download Free PDF Sample of mRNA Technology Market report @ https://www.themarketinsights.com/request-sample/265166

The recent COVID-19 outbreak has been a launching year for the mRNA technology platforms with the extensive use of mRNA vaccines for treating COVID-19. The market has observed skyrocketed sales of COVID-19 mRNA vaccines during 2020 and 2021. Moreover, the fact that mRNA vaccines hold much more potential than current prophylactic COVID-19 vaccines coupled with the soaring investments in the development of mRNA-based technologies and the perception that COVID-19 will continue to affect the global population, the market for mRNA technologies is expected to witness a steady decline in the few upcoming years.

Market Segmentation:

The rise in the prevalence of cancer is expected to provide significant growth opportunities for the market during the forecast period. For instance, according to the World Health Organization (WHO), cancer is one of the leading causes of mortalities globally which accounted for around 10 million mortalities in 2020.

Get Discount @ https://www.themarketinsights.com/check-discount/265166

Cancer-causing infections such as hepatitis and human papillomavirus are responsible for 30% of cancer cases in low and lower-middle-income countries. Moreover in 2021, according to the National Center for Health Statistics, 1,896,180 new cases cancer cases and 608,570 cancer mortalities were recorded in the US.

Market Structure and Competitive Landscape:

The global mRNA technology market is competitive and consists of a number of global and regional players operating in the market. Pharmaceutical companies are investing in mRNA technology as it allows them to mix numerous molecules into a therapeutic drug, which is another important growth factor.

The major companies in the market include Moderna Therapeutics, BioNTech, Ethris, CureVac, Argos Therapeutics, Sangamo Therapeutics Inc., Pfizer Inc, Biocon, Tiba Biotechnology, Verve Therapeutics Ltd. and many more. Diversified portfolios of leading firms in innovations and R&D activities characterize the global market, and they are likely to prioritize mergers and acquisitions, and collaborations.

Report Customization available as per requirements @ https://www.themarketinsights.com/request-customization/265166

Recent developments observed in the market include:

1. In June 2022, Pfizer Inc. announced to invest US$ 120 million in its Kalamazoo, Michigan, facility, enabling U.S.-based production in support of its COVID-19 oral treatment, PAXLOVIDTM (nirmatrelvir tablets and ritonavir tablets).

2. In January 2022, Pfizer Inc. and BioNTech SE announced a new research, development, and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention of shingles (herpes zoster virus, or HZV), a debilitating, disfiguring, and painful disease. The collaboration builds on the companies success in developing the first approved and most widely used mRNA vaccine to help prevent COVID-19.

Partial Table of Content:
Chapter One: Market Introduction
1.1. Scope of Study
1.2. Problem Statement
1.3. Market Segmentation

Chapter Two: Assumptions and Acronyms

Chapter Three: Executive Summary
3.1. Global Market in2022
3.2. Analyst Insights & Recommendations
3.3. Growth Opportunities and Key Strategies
3.4. Supply-side and Demand-side Trends

Chapter Four: Research Methodology

Contact us:

Jessica Joyal
+16146022897
Email: sales@themarketinsights.com
Visit our website: www.themarketinsights.com

About:

Delivering foresights along with statistical analysis of the operational business industry impacts has been our foremost priority. With the constant developments in the research & development industry, we have always challenged the conventional research methodologies and discovered new research tactics to evolve the growing B2B requirements.

This release was published on openPR.